BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wierzbicki PM, Adrych K, Kartanowicz D, Stanislawowski M, Kowalczyk A, Godlewski J, Skwierz-Bogdanska I, Celinski K, Gach T, Kulig J, Korybalski B, Kmiec Z. Underexpression of LATS1 TSG in colorectal cancer is associated with promoter hypermethylation. World J Gastroenterol 2013; 19(27): 4363-4373 [PMID: 23885148 DOI: 10.3748/wjg.v19.i27.4363]
URL: https://www.wjgnet.com/1007-9327/full/v19/i27/4363.htm
Number Citing Articles
1
Piotr M. Wierzbicki, Jakub Klacz, Agnieszka Rybarczyk, Tomasz Slebioda, Marcin Stanislawowski, Agata Wronska, Anna Kowalczyk, Marcin Matuszewski, Zbigniew Kmiec. Identification of a suitable qPCR reference gene in metastatic clear cell renal cell carcinomaTumor Biology 2014; 35(12): 12473 doi: 10.1007/s13277-014-2566-9
2
Jinyun Li, Chongchang Zhou, Shumin Ni, Shaomin Wang, Chao Ni, Ping Yang, Meng Ye. Methylatedclaudin-11associated with metastasis and poor survival of colorectal cancerOncotarget 2017; 8(56): 96249 doi: 10.18632/oncotarget.21997
3
Tomasz Jerzy Ślebioda, Marcin Stanisławowski, Marta Cyman, Piotr Mieczysław Wierzbicki, Dorota Żurawa-Janicka, Jarek Kobiela, Wojciech Makarewicz, Marek Guzek, Zbigniew Kmieć. Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon CancerDigestive Diseases and Sciences 2019; 64(7): 1857 doi: 10.1007/s10620-019-05507-8
4
Bing Xu, Duoxiang Sun, Zhihua Wang, Haiyan Weng, Dabao Wu, Xuefen Zhang, Ying Zhou, Weiping Hu. Expression of LATS family proteins in ovarian tumors and its significanceHuman Pathology 2015; 46(6): 858 doi: 10.1016/j.humpath.2015.02.012
5
Ahmad A.D. Sharif, Alexander Hergovich. The NDR/LATS protein kinases in immunology and cancer biologySeminars in Cancer Biology 2018; 48: 104 doi: 10.1016/j.semcancer.2017.04.010
6
Jihong Deng, Wen Zhang, Shuangyue Liu, Hongmei An, Lu Tan, Lisha Ma. LATS1 suppresses proliferation and invasion of cervical cancerMolecular Medicine Reports 2017; 15(4): 1654 doi: 10.3892/mmr.2017.6180
7
Magdalena Szarynska, Agata Olejniczak, Piotr Wierzbicki, Jaroslaw Kobiela, Dariusz Laski, Zbigniew Sledzinski, Krystian Adrych, Marek Guzek, Zbigniew Kmiec. FasR and FasL in colorectal cancerInternational Journal of Oncology 2017; 51(3): 975 doi: 10.3892/ijo.2017.4083
8
Yu Wang, Li-Hua Huang, Can-Xia Xu, Jing Xiao, Li Zhou, Dan Cao, Xiao-Min Liu, Yong Qi. <italic>Connexin 32</italic> and <italic>43</italic> promoter methylation in <italic>Helicobacter pylori</italic>-associated gastric tumorigenesisWorld Journal of Gastroenterology 2014; 20(33): 11770-11779 doi: 10.3748/wjg.v20.i33.11770
9
Kimberly C. Lin, Hyun Woo Park, Kun-Liang Guan. Deregulation and Therapeutic Potential of the Hippo Pathway in CancerAnnual Review of Cancer Biology 2018; 2(1): 59 doi: 10.1146/annurev-cancerbio-030617-050202
10
Hongling Li, Dezhuan Da, Wenqiang Yu, Lu Chen, Shuai Yang, Baolong Zhang, Yongying Wang, Linyu Li, Chunyan Dang. Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLCHuman Molecular Genetics 2023; 32(1): 79 doi: 10.1093/hmg/ddac185
11
KE-HONG CHEN, JIANG HE, DE-LIN WANG, JIAN-JIA CAO, MEI-CAI LI, XIU-MIN ZHAO, XIA SHENG, WEN-BIN LI, WU-JIANG LIU. Methylation-associated inactivation of LATS1 and its effect on demethylation or overexpression on YAP and cell biological function in human renal cell carcinomaInternational Journal of Oncology 2014; 45(6): 2511 doi: 10.3892/ijo.2014.2687
12
Mohammad Ayoub Rigi Ladiz, Maryam Najafi, Dor Mohammad Kordi-Tamandani. Contribution of LATS1 and LATS2 promoter methylation in OSCC developmentJournal of Cell Communication and Signaling 2017; 11(1): 49 doi: 10.1007/s12079-016-0356-4
13
Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North IndiaGene 2018; 676: 156 doi: 10.1016/j.gene.2018.07.033
14
Marc Riffet, Yassine Eid, Maxime Faisant, Audrey Fohlen, Benjamin Menahem, Arnaud Alves, Fatéméh Dubois, Guénaelle Levallet, Céline Bazille. Deciphering Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Reveals the Poor Prognostic Factor of RASSF2 Gene Silencing in Colon CancersCancers 2021; 13(23): 5957 doi: 10.3390/cancers13235957
15
Jianping Zou, Ling Zhou, Yi Le, Zhi Fang, Min Zhong, Fengting Nie, Xianpin Wei, Xiaomei Zhang, Zhen Chen, Lingling Cai, Heng Wang, Jianping Xiong, Ziling Fang, Xiaojun Xiang. WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 proteinCell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01050-2
16
Daniel A Barron, Jacob D Kagey. The role of the Hippo pathway in human disease and tumorigenesisClinical and Translational Medicine 2014; 3(1) doi: 10.1186/2001-1326-3-25
17
Maryam Najafi, Dor Mohammad Kordi-Tamandani, Mohammad Arish. Evaluation ofLATS1andLATS2Promoter Methylation with the Risk of Pterygium FormationJournal of Ophthalmology 2016; 2016: 1 doi: 10.1155/2016/5431021
18
Yu-Han Hu, Qing Chen, Yan-Xia Lu, Jian-Ming Zhang, Chun Lin, Fan Zhang, Wen-Juan Zhang, Xiao-Min Li, Wei Zhang, Xue-Nong Li. Hypermethylation of NDN promotes cell proliferation by activating the Wnt signaling pathway in colorectal cancerOncotarget 2017; 8(28): 46191 doi: 10.18632/oncotarget.17580
19
Steven W. Plouffe, Zhipeng Meng, Kimberly C. Lin, Brian Lin, Audrey W. Hong, Justin V. Chun, Kun-Liang Guan. Characterization of Hippo Pathway Components by Gene InactivationMolecular Cell 2016; 64(5): 993 doi: 10.1016/j.molcel.2016.10.034
20
Shivani Singh, Saurav Panicker, Satish Ramalingam. Cancer Genes2023; : 159 doi: 10.2174/9789815080292123010009
21
Liang Xu, Peixue Li, Xue Hao, Yi Lu, Mingxian Liu, Wenqian Song, Lin Shan, Jiao Yu, Hongyu Ding, Shishuang Chen, Ailing Yang, Yi Arial Zeng, Lei Zhang, Hai Jiang. SHANK2 is a frequently amplified oncogene with evolutionarily conserved roles in regulating Hippo signalingProtein & Cell 2021; 12(3): 174 doi: 10.1007/s13238-020-00742-6
22
Mona K. Saadeldin, Heba Shawer, Ahmed Mostafa, Neemat M. Kassem, Asma Amleh, Rania Siam. New genetic variants of LATS1 detected in urinary bladder and colon cancerFrontiers in Genetics 2015; 5 doi: 10.3389/fgene.2014.00425
23
Wei Song, Jingjing Zhang, Jianbo Zhang, Miaomiao Sun, Qingxin Xia. Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cellsCancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0857-3
24
Ankita Sharma, Rafeeq Mir, Sanjeev Galande. Epigenetic Regulation of the Wnt/β-Catenin Signaling Pathway in CancerFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.681053
25
Rumi Shin, Seongdae Lee, Kyung-Su Han, Dae Kyung Sohn, Sang Hui Moon, Dong Hyun Choi, Bong-Hyeon Kye, Hae-Jung Son, Sun Il Lee, Sumin Si, Won-Kyung Kang. Guidelines for accreditation of endoscopy units: quality measures from the Korean Society of ColoproctologyAnnals of Surgical Treatment and Research 2021; 100(3): 154 doi: 10.4174/astr.2021.100.3.154
26
Wei Kang, Alfred SL Cheng, Jun Yu, Ka Fai To. Emerging role of Hippo pathway in gastric and other gastrointestinal cancersWorld Journal of Gastroenterology 2016; 22(3): 1279-1288 doi: 10.3748/wjg.v22.i3.1279
27
Yiu To Yeung, Angelica Guerrero-Castilla, Mercedes Cano, Mario F. Muñoz, Antonio Ayala, Sandro Argüelles. Dysregulation of the Hippo pathway signaling in aging and cancerPharmacological Research 2019; 143: 151 doi: 10.1016/j.phrs.2019.03.018
28
Showkat A. Malik, Mosin S. Khan, Majeed Dar, Mahboob Ul Hussain, Mohammad A. Shah, Sheikh M. Shafi, Syed Mudassar. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung CarcinomaPathology & Oncology Research 2018; 24(2): 207 doi: 10.1007/s12253-017-0225-3
29
Yi Pan, Joanna Hung Man Tong, Raymond Wai Ming Lung, Wei Kang, Johnny Sheung Him Kwan, Wing Po Chak, Ka Yee Tin, Lau Ying Chung, Feng Wu, Simon Siu Man Ng, Tony Wing Chung Mak, Jun Yu, Kwok Wai Lo, Anthony Wing Hung Chan, Ka Fai To. RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancerMolecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0853-6
30
Steven W. Plouffe, Audrey W. Hong, Kun-Liang Guan. Disease implications of the Hippo/YAP pathwayTrends in Molecular Medicine 2015; 21(4): 212 doi: 10.1016/j.molmed.2015.01.003
31
Yi Wang, Minhao Chen. Decreased expression of LATS1 correlates with astrogliosis after spinal cord injuryBiochemical and Biophysical Research Communications 2018; 505(1): 151 doi: 10.1016/j.bbrc.2018.09.025
32
J.M. WIERZBICKA, A. BINEK, T. AHRENDS, J.D. NOWAC KA, A. SZYDŁOWSKA, Ł. TURCZYK, T. WĄSIEWICZ, P.M. WIERZBICKI, R. SĄDEJ, R.C. TUCKEY, A.T. SLOMINSKI, J. CHYBICKI, K. ADRYCH, Z. KMIEĆ, M.A. ŻMIJEWSKI. Differential antitumor effects of vitamin D analogues on colorectal carcinoma in cultureInternational Journal of Oncology 2015; 47(3): 1084 doi: 10.3892/ijo.2015.3088
33
Fa-Xing Yu, Zhipeng Meng, Steven W. Plouffe, Kun-Liang Guan. Hippo Pathway Regulation of Gastrointestinal TissuesAnnual Review of Physiology 2015; 77(1): 201 doi: 10.1146/annurev-physiol-021014-071733
34
Ji-Eun Oh, Takashi Ohta, Kaishi Satomi, Matthieu Foll, Geoffroy Durand, James McKay, Florence Le Calvez-Kelm, Michel Mittelbronn, Benjamin Brokinkel, Werner Paulus, Hiroko Ohgaki. Alterations in the NF2/LATS1/LATS2/YAP Pathway in SchwannomasJournal of Neuropathology & Experimental Neurology 2015; 74(10): 952 doi: 10.1097/NEN.0000000000000238
35
Pinelopi Nterma, Eleni Panopoulou, Eleni Papadaki-Petrou, Martha Assimakopoulou. Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal IntestinePathology & Oncology Research 2020; 26(1): 567 doi: 10.1007/s12253-018-00575-z
36
Chanchao Lorthongpanich, Nittaya Jiamvoraphong, Kantpitchar Supraditaporn, Phatchanat Klaihmon, Yaowalak U-pratya, Surapol Issaragrisil. The Hippo pathway regulates human megakaryocytic differentiationThrombosis and Haemostasis 2017; 117(01): 116 doi: 10.1160/TH16-07-0564
37
Noa Furth, Yael Aylon. The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathwayCell Death & Differentiation 2017; 24(9): 1488 doi: 10.1038/cdd.2017.99
38
Xu Shen, Xiaohan Sun, Bing Sun, Tao Li, Guoliang Wu, Yuantao Li, Lai Chen, Qingxin Liu, Meng Cui, Zizhang Zhou. ARRDC3 suppresses colorectal cancer progression through destabilizing the oncoprotein YAPFEBS Letters 2018; 592(4): 599 doi: 10.1002/1873-3468.12986
39
T.J. Grant, K. Hua, A. Singh. Molecular and Cellular Changes in the Cancer CellProgress in Molecular Biology and Translational Science 2016; 144: 241 doi: 10.1016/bs.pmbts.2016.09.008
40
Agnieszka Rybarczyk, Jakub Klacz, Agata Wronska, Marcin Matuszewski, Zbigniew Kmiec, Piotr M. Wierzbicki. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcomeOncology Reports 2017; 38(1): 427 doi: 10.3892/or.2017.5642
41
Feng An, Yidong Liu, Yan Hu. miR-21 inhibition of LATS1 promotes proliferation and metastasis of renal cancer cells and tumor stem cell phenotypeOncology Letters 2017; 14(4): 4684 doi: 10.3892/ol.2017.6746
42
Yurika Matsui, Yifan Zhang, Robert F. Paulson, Zhi-Chun Lai. Dual Role of a C-Terminally Truncated Isoform of Large Tumor Suppressor Kinase 1 in the Regulation of Hippo Signaling and Tissue GrowthDNA and Cell Biology 2019; 38(1): 91 doi: 10.1089/dna.2018.4340